This sounds like the discovery of the Century:- I am going to purchase this and see what happens. - Will let you know of any results. Pat. Introducing CytoLog A few of you may be relentlessly searching for "something" because you have been so ill and frustrated for so long, you now feel desperate. Many of you may find the following information unbelievable, and understandably, will reject it. With that in mind, we invite your patience in learning about something so completely different, you will not find anything else to compare it to. Cytolog Informational Peptide Technology. To date, in field and clinical use with more that 2000 infants, children and adults in twelve countries, there have been no known exceptions to CytoLog’s ability to affect the progression of any chronic degenerative disease for which it has been used. In many cases, Cytolog has induced what appears to be complete and lasting cellular recovery. This may well be one of the most important discoveries of this century in the search for authentic health and well being..... Q: What is CytoLog? A: Cytolog is a special concentration of specific low molecular weight peptides normally found in human and animal blood, milk and Colostrum. In Cytolog they are suspended in a fluid carrier and are not freeze dried, dehydrated, spray dried, pasteurized or denatured in any way. Q: How is it obtained? A: The specific peptides are separated, in a proprietary process, from bovine colostrum in such a way as to allow them to remain in a natural state without the interference or association with other peptides, proteins or any other naturally occurring constituents. CytoLog is manufactured in Northern California in a sterile environment, and in conformance with all requirements of the USA Food, Drug and Cosmetic Act, as amended and the general regulations for its enforcement. Q: So is it like Colostrum? A: Not at all. While it originates from Bovine Colostrum, in its final stage it is totally unlike colostrum or any other product we know of. Q: How does CytoLog work? A: Based on numerous clinical and field observations, our developing theory proposes that these specific protein derivatives induce anti-inflammatory cytokine-type activity by the body allowing the immune system to reorient or correct its response strategy against autoimmune disease processes. In other words, we believe that these peptides induce cellular recovery allowing the cells to relieve, and in many cases cure, themselves of their inability to respond naturally to whatever is or has been challenging them. Q: So, is Cytolog a cure? A: Not in the literal sense. We must understand that only the body can cure itself. A "substance" such as a drug cannot cure. The body may or may not use something depending on the body's priorities and its usefulness as determined by the cells. In fact, most of the time drugs interfere with the body's wise determination to restore itself, which it is constantly doing to various degrees all the time anyway. Drugs usually overwhelm the cells resistance to them and then impose or intervene in cellular processes. We call the perceived cellular response to the drug a “side effect,” which is more medically acceptable than saying it is harmful. If the appropriate resource is available, the body knows what to do with it. In clinical situations with the use of Cytolog, and depending on the challenge, the body can sometimes recover itself in a few hours. In the case of Viral Respiratory Infection in infants, the initiated recovery may begin within minutes and be mostly complete within the first hour. With Viral Respiratory Infection in infants, the recovery is seen in virtually 100 percent of the cases. Q: What is the chemical action? A: Unlike a drug, there is no apparent chemical action or function. We believe the peptides involved deliver information, analogous to computer software. This information is very basic in nature and acts as a sort of "basic operating software" directing or contributing to the cells ability to respond to immunological challenges. We call these peptides "Infopeptides." We believe this type of information is the first and most basic information nature intended to deliver to the cells of infants through colostrum from the first few days of breast feeding prior to the digestive process being initiated and becoming fully functional. In CytoLog these special peptides are more concentrated and, we believe, free of any negative environmental influences that you may find in whole colostrum at this point in time. Q: Could you be more specific? A: Initial clinical observations in humans have demonstrated marked and very rapid reductions of inflammation, edema, pain and fever regardless of the cause. CytoLog’s ability to affect a broad range of seemingly unrelated diseases, while being able to cross over into other species, suggests that there is an operating mode of influence involving the transportation of information only. It appears that CytoLog is particularly effective in the treatment of various viral and autoimmune conditions. Q: What are the practical applications for Infopeptide supplementation? A: At this time, the evaluation of Infopeptides is focused on twenty general categories of disease: Allergies, Arthritis, Benign Prostatic Hyperplasia, Cancer (adjunctive use only), Celiac Sprue, Crohn's disease, Diabetes type II, Hypertension, Lupus (discoid & systemic), Multiple Sclerosis, Perthes disease (active), Premenstrual Syndrome & Endometriosis, Prion diseases (Kuru & Creutzfeldt-Jakob syndrome), Psoriasis, Sjogren's syndrome, Spinal Muscular Atrophy, Thrombocytopenia (idiopathic & autoimmune), topical applications (burns, wounds, infections, insect bites, diaper rash & herpetic lesions), acute viral infections, and chronic viral infections. Q: What are Infopeptides? A: Infopeptides refers to a class of small proteins that are believed to act as informational media, advising and coordinating appropriate cellular functions in humans and other mammals. Information available at this time suggests that these peptides are produced in the ribosomes of cells, then circulate in the blood, and in the case of pregnant females, concentrate in the colostrum. Q: How does the body use the Infopeptides? A: The Infopeptides are absorbed through the oral mucosa and are not utilized through the digestive tract. For effective use, they have to be absorbed by live cells. This could also apply to an open wound. The cells seem to be able to clone or transfer the information to other cells in the body very fast. In infants, we have seen recovery from Viral Respiratory Infection and fever in about an hour which would be indicative of the information being shared extremely fast, especially given the total number of cells involved. Q: What are some of the most dramatic recoveries observed? A: They are numerous and range in recovery from Mononucleosis (diagnoses confirmed by blood test) in about two hours, complete recovery from 30 year old advanced and degenerative Multiple Sclerosis in about six weeks and Celiac Sprue disease in four to five days. There have also been complete resolution of symptoms from other "incurable" diseases such as Sjogren’s Syndrome and Perthes Disease (osteochondritis). Another unusual result was the complete recovery of a dog from rabies (dumb r.) within two days. Q: So, CytoLog also works for animals? A: It is effective with species other than humans. Q: How much clinical work has been done using Cytolog Infopeptides? A: More than 20 medical doctors, other associates and more than 2000 patients in twelve countries have been observed, many in clinically controlled studies and others in field observations. The first clinical study on Rheumatoid Arthritis and Osteoarthritis was published in 1998 in The Journal of Orthomolecular Medicine and there are several reports from clinical studies currently being prepared for publication. Q: How long does someone have to take CytoLog? A: In many cases people and animals have only taken it for as short a time as two weeks and have had no reoccurrence of symptoms ranging for at least five years. About 40% of the time, there is no reoccurrence of symptoms for as long as a year. About 60% of the time there can be a reoccurrence of symptoms within four to six months or so after only using CytoLog for 15 to 30 days. Consistent long-term results have yet to be determined as well as more accurate daily frequency of dosages more specific to different health challenges. Q: How is CytoLog administered? A: CytoLog comes in a pump-spray bottle and is generally sprayed into the mouth an average of five sprays two times per day (10 milliliters). There are a few other recommendations depending on what the specific disease is. Q: Is CytoLog a drug? A: CytoLog is not a drug and has no known chemical effects on the body. CytoLog is classified as a food supplement. Q: Does it have any side effects? A: The safety of Cytolog has been demonstrated in physician monitored safety studies and in normal use. There are no known side effects or contraindications. It is safe to take with anything else and is not effected by any other substance that we know of.